MX9100513A - Compuestos - Google Patents
CompuestosInfo
- Publication number
- MX9100513A MX9100513A MX9100513A MX9100513A MX9100513A MX 9100513 A MX9100513 A MX 9100513A MX 9100513 A MX9100513 A MX 9100513A MX 9100513 A MX9100513 A MX 9100513A MX 9100513 A MX9100513 A MX 9100513A
- Authority
- MX
- Mexico
- Prior art keywords
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
- C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB909017224A GB9017224D0 (en) | 1990-08-06 | 1990-08-06 | Compounds |
| GB919107757A GB9107757D0 (en) | 1991-04-12 | 1991-04-12 | Compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX9100513A true MX9100513A (es) | 1992-04-01 |
Family
ID=26297463
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9100513A MX9100513A (es) | 1990-08-06 | 1991-08-02 | Compuestos |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0542846A1 (es) |
| JP (1) | JPH06500093A (es) |
| KR (1) | KR930701402A (es) |
| CN (1) | CN1061963A (es) |
| AP (1) | AP279A (es) |
| AU (1) | AU8327191A (es) |
| CA (1) | CA2088491A1 (es) |
| IE (1) | IE912759A1 (es) |
| IL (1) | IL99073A0 (es) |
| MA (1) | MA22250A1 (es) |
| MX (1) | MX9100513A (es) |
| NZ (1) | NZ239268A (es) |
| PT (1) | PT98574A (es) |
| TW (1) | TW267164B (es) |
| WO (1) | WO1992002502A1 (es) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5109002A (en) * | 1989-09-08 | 1992-04-28 | Du Pont Merck Pharmaceutical Company | Antipsychotic 1-cycloalkylpiperidines |
| ATE182591T1 (de) * | 1991-09-12 | 1999-08-15 | Smithkline Beecham Plc | 5-ht4 rezeptor antagonisten |
| JPH07503461A (ja) * | 1992-01-28 | 1995-04-13 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | カルシウムチャンネル拮抗薬としての化合物 |
| CA2110251A1 (en) | 1992-11-30 | 1994-05-31 | Koichi Fujimoto | Alpha, omega-diarylalkane derivatives, their preparation and their use in the treatment and prevention of circulatory diseases and psychosis |
| GB9226111D0 (en) * | 1992-12-15 | 1993-02-10 | Smithkline Beecham Plc | Madicaments |
| GB9314973D0 (en) * | 1993-07-20 | 1993-09-01 | Smithkline Beecham Plc | Medicaments |
| GB9319534D0 (en) * | 1993-09-22 | 1993-11-10 | Boots Co Plc | Therapeutic agents |
| WO1995024390A1 (en) * | 1994-03-11 | 1995-09-14 | Smithkline Beecham Plc | Novel phenyl(-alkyl/alkoxy)-1-aminoalkyl-substituted piperidines and pyrrolidines as calcium channel antagonists |
| GB9411052D0 (en) * | 1994-06-02 | 1994-07-20 | Smithkline Beecham Plc | Medicaments |
| GB9411045D0 (en) * | 1994-06-02 | 1994-07-20 | Smithkline Beecham Plc | Compounds and use |
| ATE206113T1 (de) * | 1994-12-21 | 2001-10-15 | Neurosearch As | Verfahren zur herstellung von substituierten 4- ethylpiperidinen |
| AUPN037195A0 (en) * | 1995-01-03 | 1995-01-27 | Australian Nuclear Science & Technology Organisation | Piperidine-based sigma receptor ligands |
| WO1997010212A1 (en) * | 1995-09-15 | 1997-03-20 | Neurosearch A/S | Piperidine compounds as calcium channel blockers |
| FR2742051B1 (fr) * | 1995-12-06 | 1998-02-06 | Synthelabo | Utilisation de composes ayant une affinite pour le site de liaison du (3h)ifenprodil pour la fabrication de medicaments utiles dans la prevention et le traitement des neuropathies |
| ZA9610741B (en) | 1995-12-22 | 1997-06-24 | Warner Lambert Co | 4-Substituted piperidine analogs and their use as subtype selective nmda receptor antagonists |
| ZA9610738B (en) | 1995-12-22 | 1997-06-24 | Warner Lambert Co | Subtype selective nmda receptor ligands and the use thereof |
| ZA9610745B (en) * | 1995-12-22 | 1997-06-24 | Warner Lambert Co | 4-Subsituted piperidine analogs and their use as subtype selective nmda receptor antagonists |
| ZA9610736B (en) * | 1995-12-22 | 1997-06-27 | Warner Lambert Co | 2-Substituted piperidine analogs and their use as subtypeselective nmda receptor antagonists |
| EP0790235A1 (en) * | 1996-02-15 | 1997-08-20 | Sankyo Company Limited | Diaryl alkane derivatives containing an alicyclic group, their preparation and their therapeutic and prophylactic uses |
| JP2000516929A (ja) * | 1996-08-12 | 2000-12-19 | メルク エンド カンパニー インコーポレーテッド | トロンビン阻害剤 |
| WO1999043658A1 (en) | 1998-02-27 | 1999-09-02 | Warner-Lambert Company | Heterocyclic substituted aniline calcium channel blockers |
| US6166052A (en) | 1998-03-11 | 2000-12-26 | Warner-Lambert Company | Heteroaryl alkyl alpha substituted peptidylamine calcium channel blockers |
| US6011035A (en) * | 1998-06-30 | 2000-01-04 | Neuromed Technologies Inc. | Calcium channel blockers |
| JP4932994B2 (ja) * | 1999-04-07 | 2012-05-16 | ユニバーシテイ・オブ・バージニア・パテント・フアウンデーシヨン | 抗癌性カルシウムチャンネル遮断薬 |
| GB9917406D0 (en) | 1999-07-23 | 1999-09-22 | Smithkline Beecham Plc | Compounds |
| US7294637B2 (en) | 2000-09-11 | 2007-11-13 | Sepracor, Inc. | Method of treating addiction or dependence using a ligand for a monamine receptor or transporter |
| WO2002022572A2 (en) | 2000-09-11 | 2002-03-21 | Sepracor, Inc. | Ligands for monoamine receptors and transporters, and methods of use thereof (neurotransmission) |
| SE0103818D0 (sv) | 2001-11-15 | 2001-11-15 | Astrazeneca Ab | Chemical compounds |
| AR042628A1 (es) * | 2002-12-20 | 2005-06-29 | Astrazeneca Ab | Derivados de piperidina como moduladores del receptor ccr5 |
| SE0203828D0 (sv) * | 2002-12-20 | 2002-12-20 | Astrazeneca Ab | Chemical compounds |
| SE0301369D0 (sv) | 2003-05-09 | 2003-05-09 | Astrazeneca Ab | Chemical compounds |
| PL1641775T3 (pl) | 2003-07-03 | 2009-07-31 | Euro Celtique Sa | Pochodne 2-pirydynoalkin użyteczne do leczenia bólu |
| TW200610761A (en) | 2004-04-23 | 2006-04-01 | Astrazeneca Ab | Chemical compounds |
| SE0401656D0 (sv) * | 2004-06-24 | 2004-06-24 | Astrazeneca Ab | Chemical compounds |
| FR2872416B1 (fr) | 2004-07-01 | 2006-09-22 | Oreal | Utilisation de derives de piperidine pour lutter contre les rides |
| CA2631096A1 (en) * | 2005-09-23 | 2007-03-23 | M's Science Corporation | Piperidine and piperazine derivatives |
| PT1976525E (pt) * | 2006-01-27 | 2011-02-04 | Ms Science Corp | Derivados piperidina e piperazina |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4031221A (en) * | 1974-06-17 | 1977-06-21 | American Hoechst Corporation | Method of treating pain and hypertension |
| DE3170628D1 (en) * | 1981-10-15 | 1985-06-27 | Synthelabo | Piperidine derivatives, their preparation and use in medicine |
| US4546105A (en) * | 1984-09-04 | 1985-10-08 | Hoechst-Roussel Pharmaceuticals Inc. | Pyrrolylaminopiperidines, compositions thereof and methods of use |
| DE3441929A1 (de) * | 1984-11-16 | 1986-05-28 | Basf Ag, 6700 Ludwigshafen | Verfahren zur herstellung von substituierten piperidinen |
| DE3529994A1 (de) * | 1985-08-22 | 1987-02-26 | Hoechst Ag | Indolinonderivate, verfahren zu ihrer herstellung, sie enthaltende arzneimittel und deren verwendung |
| DK623586A (da) * | 1985-12-27 | 1987-06-28 | Eisai Co Ltd | Piperidinderivater eller salte deraf og farmaceutiske kompositioner indeholdende forbindelserne |
| MY104343A (en) * | 1987-11-23 | 1994-03-31 | Janssen Pharmaceutica Nv | Novel pyridizinamine deravatives |
| FR2636946B1 (fr) * | 1988-09-23 | 1990-11-02 | Lipha | ((diarylmethoxy)alcoyl)-1 pyrrolidines et piperidines, procedes de preparation et medicaments les contenant |
| WO1990006303A1 (en) * | 1988-12-02 | 1990-06-14 | Pfizer Inc. | Arylpiperidine derivatives |
-
1991
- 1991-08-02 MX MX9100513A patent/MX9100513A/es unknown
- 1991-08-02 IE IE275991A patent/IE912759A1/en unknown
- 1991-08-04 IL IL99073A patent/IL99073A0/xx unknown
- 1991-08-05 EP EP91914558A patent/EP0542846A1/en not_active Withdrawn
- 1991-08-05 CA CA002088491A patent/CA2088491A1/en not_active Abandoned
- 1991-08-05 TW TW080106121A patent/TW267164B/zh active
- 1991-08-05 CN CN91105945A patent/CN1061963A/zh active Pending
- 1991-08-05 JP JP3513952A patent/JPH06500093A/ja active Pending
- 1991-08-05 NZ NZ239268A patent/NZ239268A/xx unknown
- 1991-08-05 WO PCT/GB1991/001340 patent/WO1992002502A1/en not_active Application Discontinuation
- 1991-08-05 KR KR1019930700352A patent/KR930701402A/ko not_active Application Discontinuation
- 1991-08-05 MA MA22529A patent/MA22250A1/fr unknown
- 1991-08-05 AU AU83271/91A patent/AU8327191A/en not_active Abandoned
- 1991-08-05 PT PT98574A patent/PT98574A/pt not_active Application Discontinuation
- 1991-08-06 AP APAP/P/1991/000313A patent/AP279A/en active
Also Published As
| Publication number | Publication date |
|---|---|
| PT98574A (pt) | 1992-06-30 |
| AP279A (en) | 1993-08-01 |
| EP0542846A1 (en) | 1993-05-26 |
| AU8327191A (en) | 1992-03-02 |
| AP9100313A0 (en) | 1991-10-31 |
| IE912759A1 (en) | 1992-02-12 |
| JPH06500093A (ja) | 1994-01-06 |
| IL99073A0 (en) | 1992-07-15 |
| TW267164B (es) | 1996-01-01 |
| KR930701402A (ko) | 1993-06-11 |
| CA2088491A1 (en) | 1992-02-07 |
| WO1992002502A1 (en) | 1992-02-20 |
| CN1061963A (zh) | 1992-06-17 |
| MA22250A1 (fr) | 1992-04-01 |
| NZ239268A (en) | 1994-06-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX9100513A (es) | Compuestos | |
| BR1100956A (pt) | Composto | |
| ATA150090A (de) | Hoergeraet | |
| MX9100018A (es) | Histidinas sustituidas | |
| MX9100517A (es) | Compuestos | |
| MX9101501A (es) | Compuestos novedosos | |
| ATA210290A (de) | Lotpille | |
| ATA80690A (de) | Alpinschi | |
| DK106991D0 (da) | Dichloranilinforbindelser | |
| ATA200090A (de) | Pianino | |
| ATA209290A (de) | Diaraehmchen | |
| ATA237490A (de) | Rinnenstein | |
| BR9002505A (pt) | Venturbo | |
| MX9100660A (es) | Compuestos | |
| IT9020674A1 (it) | Composti ammelinici | |
| BR1101075A (pt) | Compostos azasteróides | |
| BR1100710A (pt) | Composto | |
| NO925056L (no) | Bisheterocyklisk forbindelse | |
| SE9002207D0 (sv) | New compounds i | |
| SE9001047D0 (sv) | Stroemdel foer stallar | |
| BR7001930U (pt) | Terrario | |
| BR7001467U (pt) | Halleybus | |
| BR7000286U (pt) | Barraca-bagageiro | |
| BR7000375U (pt) | Mosquiteiro baby-ju | |
| BR7000491U (pt) | Loteria zoonumerica futebolistica |